PubMed:32712670 / 396-700 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T14","span":{"begin":9,"end":18},"obj":"CHEBI:31781"},{"id":"T15","span":{"begin":9,"end":18},"obj":"DG_23"},{"id":"T16","span":{"begin":9,"end":18},"obj":"CHEBI:31781"},{"id":"T17","span":{"begin":23,"end":32},"obj":"DG_13"},{"id":"T18","span":{"begin":84,"end":95},"obj":"GO:0007565"},{"id":"T19","span":{"begin":130,"end":139},"obj":"DG_23"},{"id":"T20","span":{"begin":160,"end":169},"obj":"DG_13"},{"id":"T21","span":{"begin":191,"end":198},"obj":"UBERON:0000995"},{"id":"T22","span":{"begin":199,"end":214},"obj":"UBERON:0002450"},{"id":"T23","span":{"begin":219,"end":225},"obj":"UBERON:0000395"},{"id":"T24","span":{"begin":226,"end":232},"obj":"UBERON:0001637"},{"id":"T25","span":{"begin":252,"end":257},"obj":"SP_6"},{"id":"T26","span":{"begin":252,"end":257},"obj":"NCBITaxon:9606"},{"id":"T27","span":{"begin":270,"end":275},"obj":"NCBITaxon:10088"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Two PIs, lopinavir and darunavir, currently offered as cART options in HIV-positive pregnancies were evaluated, and we found that lopinavir-based cART, but not darunavir-based cART, impaired uterine decidualization and spiral artery remodeling in both human ex vivo and mouse in vivo experimental models."}

{"project":"Inflammaging","denotations":[{"id":"T5","span":{"begin":0,"end":304},"obj":"Sentence"},{"id":"T5","span":{"begin":0,"end":304},"obj":"Sentence"}],"text":"Two PIs, lopinavir and darunavir, currently offered as cART options in HIV-positive pregnancies were evaluated, and we found that lopinavir-based cART, but not darunavir-based cART, impaired uterine decidualization and spiral artery remodeling in both human ex vivo and mouse in vivo experimental models."}